Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

2 results

  • Chapter 11 - Management of hydrosalpinges
  • from Section 1 - Patient selection and preparation
  • Edited by Gab Kovacs, Monash University, Victoria
  • Book: How to Improve your ART Success Rates
  • Published online: 05 July 2011
  • Print publication: 30 June 2011, pp 57-62
  • View extract

    Summary

    Appropriate management of hydrosalpinges is an important key in improving in vitro fertilization (IVF) success rates. The place of reconstructive surgery is debated as IVF success rates, possibly combined with complementary surgery in case of hydrosalpinges, continue to improve. Salpingostomy by a laparoscopic or laparotomy approach, aims to create a new ostium of the fallopian tube with well-everted fimbrial mucosa, in the case of distal tubal occlusion. Hydrosalpinx fluid can be aspirated under transvaginal ultrasound guidance at any stage in the IVF process, including the stage of oocyte retrieval. The patient burden, surgical risks, and drawbacks of each specific treatment necessitate the best available evidence for a two-step approach in the management of tubal factor infertility. A Cochrane systematic review of randomized controlled trials (RCTs) was updated in 2009 to assess and compare the value of surgical treatments for tubal disease prior to IVF.